Crispr Therapeutics Ag (CRSP)

Cost of Revenue

$44.57M

Quarterly · Period ending: · USD

CRSP logo

CRSP Cost of Revenue

Latest reported$44.57M
CRSP Quarterly Cost of Revenue ($1.16M → $44.57M)
High-resolution chart · PNG

CRSP cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
44,572,000
50,249,000
59,364,000
64,693,000
49,753,000
57,509,000
0
15,953,000
56,976,000
51,799,000
20,000,000
23,422,000
44,636,000
42,192,000
6,823,000
38,859,000
33,922,000
30,646,000
134,919,000
22,464,000
26,945,000
19,945,000
82,365,000
71,008,000
59,380,000
54,193,000
48,761,000
57,246,000
39,533,000
28,860,000
28,801,000
39,820,000
25,633,000
19,519,000
20,030,000
17,845,000
17,120,000
14,805,000
15,572,000
12,052,000
8,602,000
6,012,000
6,174,000
3,749,000
1,486,000
1,164,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.